PE20181498A1 - MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN ADENOVIRUS ANTIGEN PIII (ADV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY ADV - Google Patents
MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN ADENOVIRUS ANTIGEN PIII (ADV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY ADVInfo
- Publication number
- PE20181498A1 PE20181498A1 PE2018001294A PE2018001294A PE20181498A1 PE 20181498 A1 PE20181498 A1 PE 20181498A1 PE 2018001294 A PE2018001294 A PE 2018001294A PE 2018001294 A PE2018001294 A PE 2018001294A PE 20181498 A1 PE20181498 A1 PE 20181498A1
- Authority
- PE
- Peru
- Prior art keywords
- adv
- monoclonal antibodies
- piii
- hybridomas
- secreted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Referido a a anticuerpos monoclonales, o fragmentos de estos, que se unen a la proteina plll del Adenovirus (ADV), caracterizado porque comprende una region variable de la cadena pesada que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 1 o SEQ ID No: 5 y una region variable de la cadena liviana que tiene una secuencia con al menos un 90%, 95% o 99% de identidad con la SEQ ID No: 2 o SEQ ID No: 6. Tambien se refiere a las secuencias nucleotidicas que definen dichos anticuerpos, metodos in vitro y/o ex vivo de diagnostico de infeccion por ADV en una muestra biologica que utilizan dichos anticuerpos monoclonales; y kits de diagnostico para detectar ADV, que comprenden al menos un anticuerpo monoclonal contra ADV.Referring to monoclonal antibodies, or fragments of these, that bind to the plll protein of Adenovirus (ADV), characterized in that it comprises a variable region of the heavy chain that has a sequence with at least 90%, 95% or 99% of Identity to SEQ ID No: 1 or SEQ ID No: 5 and a light chain variable region having a sequence with at least 90%, 95% or 99% identity to SEQ ID No: 2 or SEQ ID No: 6. Also refers to the nucleotide sequences that define said antibodies, in vitro and / or ex vivo methods of diagnosing ADV infection in a biological sample using said monoclonal antibodies; and diagnostic kits for detecting ADV, comprising at least one monoclonal antibody against ADV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2016000164A CL2016000164A1 (en) | 2016-01-21 | 2016-01-21 | Monoclonal antibodies specific for the human adenovirus piii antigen (adv), produced and secreted by cellular hybridomas, useful for the detection and diagnosis of adv caused infection. |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20181498A1 true PE20181498A1 (en) | 2018-09-18 |
Family
ID=56610130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2018001294A PE20181498A1 (en) | 2016-01-21 | 2017-01-20 | MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN ADENOVIRUS ANTIGEN PIII (ADV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY ADV |
Country Status (14)
Country | Link |
---|---|
US (1) | US10766948B2 (en) |
EP (2) | EP3756685A1 (en) |
CN (1) | CN108697796B (en) |
AR (1) | AR107440A1 (en) |
BR (1) | BR112018014538A2 (en) |
CA (1) | CA3011569A1 (en) |
CL (1) | CL2016000164A1 (en) |
ES (1) | ES2898068T3 (en) |
MX (1) | MX2018008809A (en) |
PE (1) | PE20181498A1 (en) |
PT (1) | PT3406262T (en) |
UY (1) | UY37082A (en) |
WO (1) | WO2017125892A2 (en) |
ZA (1) | ZA201804705B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2018003869A1 (en) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Monoclonal antibodies specific for human parainfluenza virus chimeric protein I (piv), nucleotide sequences; PIV infection diagnostic method and kit |
CN113354727B (en) * | 2021-08-10 | 2021-11-02 | 北京溯本源和生物科技有限公司 | Monoclonal antibody and test strip for simultaneously detecting B/C/E group adenovirus |
CN118027181A (en) * | 2023-06-14 | 2024-05-14 | 珠海重链生物科技有限公司 | Hexon protein antibodies and uses thereof |
CN117586385B (en) * | 2023-11-23 | 2024-05-17 | 广州医科大学附属第一医院(广州呼吸中心) | Anti-human adenovirus type 4 neutralizing antibody, preparation method and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4487829A (en) | 1982-03-23 | 1984-12-11 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies against adenoviruses |
US6248514B1 (en) * | 1996-07-09 | 2001-06-19 | Canji, Inc. | Methods for measuring viral infectivity |
US7776542B1 (en) | 1997-08-04 | 2010-08-17 | Advanced Life Science Institute | Methods for the detection of hepatitis B and C viruses |
EP1301541A2 (en) * | 2000-07-10 | 2003-04-16 | Novartis AG | Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
WO2005023848A2 (en) * | 2003-09-09 | 2005-03-17 | Gardner, Rebecca, Katherine | Adenoviral epitopes |
WO2005054469A1 (en) * | 2003-12-05 | 2005-06-16 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health | Anti-sars monoclonal antibodies |
US8003108B2 (en) * | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
CN107098970B (en) * | 2007-05-03 | 2021-11-23 | 新加坡科技研究局 | Antibodies that bind to intracellular PRL-1 or PRL-3 polypeptides |
-
2016
- 2016-01-21 CL CL2016000164A patent/CL2016000164A1/en unknown
-
2017
- 2017-01-20 MX MX2018008809A patent/MX2018008809A/en unknown
- 2017-01-20 BR BR112018014538-6A patent/BR112018014538A2/en unknown
- 2017-01-20 AR ARP170100158A patent/AR107440A1/en unknown
- 2017-01-20 CN CN201780007470.2A patent/CN108697796B/en active Active
- 2017-01-20 EP EP20166433.1A patent/EP3756685A1/en active Pending
- 2017-01-20 EP EP17741167.5A patent/EP3406262B1/en active Active
- 2017-01-20 PT PT177411675T patent/PT3406262T/en unknown
- 2017-01-20 WO PCT/IB2017/050312 patent/WO2017125892A2/en active Application Filing
- 2017-01-20 CA CA3011569A patent/CA3011569A1/en active Pending
- 2017-01-20 ES ES17741167T patent/ES2898068T3/en active Active
- 2017-01-20 PE PE2018001294A patent/PE20181498A1/en unknown
- 2017-01-20 US US16/070,730 patent/US10766948B2/en active Active
- 2017-01-20 UY UY0001037082A patent/UY37082A/en not_active Application Discontinuation
-
2018
- 2018-07-13 ZA ZA2018/04705A patent/ZA201804705B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018014538A2 (en) | 2018-12-26 |
EP3406262A4 (en) | 2019-01-09 |
PT3406262T (en) | 2021-11-03 |
ES2898068T3 (en) | 2022-03-03 |
CN108697796A (en) | 2018-10-23 |
WO2017125892A2 (en) | 2017-07-27 |
UY37082A (en) | 2017-04-28 |
US20190048065A1 (en) | 2019-02-14 |
CL2016000164A1 (en) | 2016-07-29 |
EP3756685A1 (en) | 2020-12-30 |
AR107440A1 (en) | 2018-05-02 |
EP3406262A2 (en) | 2018-11-28 |
ZA201804705B (en) | 2019-09-25 |
US10766948B2 (en) | 2020-09-08 |
WO2017125892A3 (en) | 2018-04-12 |
EP3406262B1 (en) | 2021-07-28 |
MX2018008809A (en) | 2018-11-29 |
CN108697796B (en) | 2023-01-10 |
CA3011569A1 (en) | 2017-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20220004A1 (en) | SPECIFIC MONOCLONAL ANTIBODIES TO ANTIGEN P OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (HSRV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY HRSV | |
PE20190975A1 (en) | NOVEL CD47 MONOCLONAL ANTIBODIES AND THEIR USES | |
PE20181498A1 (en) | MONOCLONAL ANTIBODIES SPECIFIC TO HUMAN ADENOVIRUS ANTIGEN PIII (ADV), PRODUCED AND SECRETED BY CELLULAR HYBRIDOMAS, USEFUL FOR THE DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY ADV | |
CO6710903A2 (en) | An antibody that specifically recognizes and binds with a phospho-epitope in the mammalian tau protein or in one of its fragments and a composition comprising the same | |
BR112018016226A8 (en) | Human monoclonal antilipoarabinomannan (anti-lam) antibody, kit for detecting at least one lam epitope, method for diagnosing an active tuberculosis infection in an individual, method for treating a tuberculosis infection in an individual, human anti-lam monoclonal antibody and lam preconcentration method from a biological sample | |
AR101848A1 (en) | ANTI-B7-H4 AND IMMUNOCATE PLAYERS | |
AR084210A1 (en) | PROTEINS OF UNION TO TNF-a | |
EA201490825A1 (en) | TDP-43-SPECIFICALLY BINDING MOLECULES | |
EA201590459A1 (en) | SPECIFIC ANTIBODIES TO ISLAND AMYLOID HUMAN POLYPEPTIDE (HIAPP) AND THEIR APPLICATION | |
PE20110797A1 (en) | ANTI MN ANTIBODIES | |
PE20140882A1 (en) | NEUTRALIZING ANTIBODIES OF HUMAN CYTOMEGALOVIRUS | |
RU2011121818A (en) | METHOD FOR IMMUNOLOGICAL ANALYSIS OF HUMAN PROTEIN CXCL1 | |
AR104264A1 (en) | NEUTRALIZATION OF CHIKUNGUNYA VIRUS MEDIATED BY ANTIBODIES | |
PE20220708A1 (en) | ANTI-CD73 ANTIBODIES | |
AR114274A1 (en) | ANTIBODIES DIRECTED AGAINST PLA2-GIB AND THE USES OF SAME | |
CO2022006909A2 (en) | Yellow fever virus antibodies and methods of their generation and use | |
CO2021011944A2 (en) | CD33 Antibodies and Methods of Using Them to Treat Cancer | |
AR117735A1 (en) | MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO REGION b OF THE HUMAN T-CELL RECEPTOR FAMILY TRBV-9, AND METHODS FOR ITS USE | |
CO2019002599A2 (en) | Protein biomarkers for diseases associated with the contact activation system | |
CO2021008770A2 (en) | Monoclonal antibodies specific for human parainfluenza virus chimeric protein I (piv), nucleotide sequences; PIV infection diagnostic method and kit | |
CO2021008774A2 (en) | Monoclonal antibodies specific for human influenza virus (flu) pb2 antigen, nucleotide sequences; flu infection diagnostic method and kit | |
AR102966A1 (en) | SPECIFIC MONOCLONAL ANTIBODIES FOR THE ANTIGEN M OF THE HUMAN METAPNEUMOVIRUS VIRUS (hMPV), PRODUCED AND SECRETED BY CELLULAR HYBRIDIDES, USEFUL FOR THE DETECTION AND DIAGNOSIS OF THE INFECTION CAUSED BY hMPV | |
AR099604A1 (en) | METALOPROTEINASE MATRIX 9 ANTIBODIES AND THEIR METHODS OF USE | |
SG11201901435UA (en) | Monoclonal antibody against melk and utilization thereof | |
AR114380A1 (en) | VARIANTS OF AB, ASSAY, METHOD AND TREATMENT OF ALZHEIMER'S DISEASE |